European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- L-cysteine, L-leucyl-L-alpha-glutamyl-L-alpha-glutamyl-L-lys
Community Register of medicinal products
Community register of orphan medicinal products | GRANTED |
Product information |
L-cysteine, L-leucyl-L-alpha-glutamyl-L-alpha-glutamyl-L-lysyl-L-lysylglycyl-L-asparaginyl-L-tyrosyl-L-valyl-L-valyl-L-threonyl-L-alpha-aspartyl-L-histidyl-S-[1-[(4-carboxycyclohexyl)methyl]-2,5-dioxo-3-pyrrolidinyl]-, complex with keyhole limpet haemocyanin
| EU orphan designation number: | EU/3/11/923
|
| Active ingredient: | L-cysteine, L-leucyl-L-alpha-glutamyl-L-alpha-glutamyl-L-lysyl-L-lysylglycyl-L-asparaginyl-L-tyrosyl-L-valyl-L-valyl-L-threonyl-L-alpha-aspartyl-L-histidyl-S-[1-[(4-carboxycyclohexyl)methyl]-2,5-dioxo-3-pyrrolidinyl]-, complex with keyhole limpet haemocyanin |
| Indication: | Treatment of glioma |
| Sponsor: | Orphix Consulting GmbH
Steinsdorfstraße 19, D-80538 München, Deutschland |
Public summary of scientific opinion
